EIF2AK3 and lung cancer: The list of cancers overexpressing HSPA5 is discussed above; Oncomine and TIMER databases indicate that PERK is overexpressed in breast cancer, liver cancer, lung cancer, gastric carcinoma, lymphoma, thyroid cancer, leukemia, and head and neck squamous cell carcinomas [130].